139961-17-4Relevant academic research and scientific papers
9-purinyl phosphonic acid derivitives for treating gout
-
, (2008/06/13)
This invention relates to novel purine nucleoside phosphorylase inhibitors, to the methods and intermediates for their preparation and to their use as immunosuppressants, antilymphoma, antileukemic, antiviral and antiprotozoal agents.
Fluorophosphonate derivatives of N9-benzylguanine as potent, slow-binding multisubstrate analogue inhibitors of purine nucleoside phosphorylase
Halazy,Ehrhard,Eggenspiller,Berges-Gross,Danzin
, p. 177 - 184 (2007/10/02)
The phosphonate derivatives of N9-benzylguanine (4a-4h) have been prepared as purine nucleoside phosphorylase inhibitors. Enzyme inhibition studies with PNP from calf spleen or human erythrocyte show that compounds 4b and 4c are among the best PNP inhibitors ever reported, demonstrating further the importance of fluorines in such type of inhibitors.
